Home/Filings/4/0000905148-25-003555
4//SEC Filing

VIKING GLOBAL INVESTORS LP 4

Accession 0000905148-25-003555

CIK 0002007919other

Filed

Oct 8, 8:00 PM ET

Accepted

Oct 9, 4:41 PM ET

Size

21.6 KB

Accession

0000905148-25-003555

Insider Transaction Report

Form 4
Period: 2025-10-07
Transactions
  • Sale

    Common Stock

    2025-10-07$32.25/sh308,643$9,953,7371,267,823 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh25,042$807,605102,864 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh16,315$526,15967,018 total(indirect: See Explanation of Responses)
Transactions
  • Sale

    Common Stock

    2025-10-07$32.25/sh308,643$9,953,7371,267,823 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh25,042$807,605102,864 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh16,315$526,15967,018 total(indirect: See Explanation of Responses)
Transactions
  • Sale

    Common Stock

    2025-10-07$32.25/sh308,643$9,953,7371,267,823 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh16,315$526,15967,018 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh25,042$807,605102,864 total(indirect: See Explanation of Responses)
Transactions
  • Sale

    Common Stock

    2025-10-07$32.25/sh16,315$526,15967,018 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh308,643$9,953,7371,267,823 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh25,042$807,605102,864 total(indirect: See Explanation of Responses)
Transactions
  • Sale

    Common Stock

    2025-10-07$32.25/sh16,315$526,15967,018 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh308,643$9,953,7371,267,823 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh25,042$807,605102,864 total(indirect: See Explanation of Responses)
Ott David C.
10% Owner
Transactions
  • Sale

    Common Stock

    2025-10-07$32.25/sh16,315$526,15967,018 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh25,042$807,605102,864 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh308,643$9,953,7371,267,823 total(indirect: See Explanation of Responses)
Transactions
  • Sale

    Common Stock

    2025-10-07$32.25/sh308,643$9,953,7371,267,823 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh25,042$807,605102,864 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh16,315$526,15967,018 total(indirect: See Explanation of Responses)
Transactions
  • Sale

    Common Stock

    2025-10-07$32.25/sh308,643$9,953,7371,267,823 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh16,315$526,15967,018 total(indirect: See Explanation of Responses)
  • Sale

    Common Stock

    2025-10-07$32.25/sh25,042$807,605102,864 total(indirect: See Explanation of Responses)
Footnotes (6)
  • [F1]Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP ("VGI"), and Viking Global Opportunities Parent GP LLC ("Opportunities Parent"), the sole member of Viking Global Opportunities GP LLC ("Opportunities GP"), the sole member of Viking Global Opportunities Portfolio GP LLC ("Opportunities Portfolio GP"), the general partner of Viking Global Opportunities Illiquid Investments Sub-Master LP ("Opportunities Fund"). Opportunities Parent is also the sole member of Viking Global Opportunities Drawdown GP LLC ("VGOD GP"), the sole member of Viking Global Opportunities Drawdown Portfolio GP LLC ("VGOD Portfolio GP"), the general partner of Viking Global Opportunities Drawdown (Aggregator) LP ("VGOD").
  • [F2]VGI provides managerial services to various investment funds and vehicles, including Opportunities Fund, VGOD, and KAVRA 104 LLC ("KAVRA 104"). VGI, Opportunities Parent, Opportunities GP, Opportunities Portfolio GP, Opportunities Fund, Mr. Halvorsen, Mr. Ott and Ms. Shabet are, collectively, the "Reporting Persons." Each of VGI, Mr. Halvorsen, Mr. Ott and Ms. Shabet may be deemed to beneficially own all of the securities reported on this form.
  • [F3]These shares of Common Stock are held directly by Opportunities Fund. Because of the relationship between Opportunities Portfolio GP, Opportunities GP, Opportunities Parent and Opportunities Fund, each of Opportunities Portfolio GP, Opportunities GP and Opportunities Parent may be deemed to beneficially own the securities held directly by Opportunities Fund.
  • [F4]These shares of Common Stock are held directly by KAVRA 104. The membership interests of KAVRA 104 are held by Viking Global Opportunities LP and Viking Global Opportunities Intermediate LP. Opportunities GP is the general partner of Viking Global Opportunities LP and Viking Global Opportunities Intermediate LP. Because of the relationship between Opportunities GP, Opportunities Parent and KAVRA 104, each of Opportunities GP and Opportunities Parent may be deemed to beneficially own the shares of Common Stock held directly by KAVRA 104.
  • [F5]These shares of Common Stock are held directly by VGOD. Because of the relationship between Opportunities Parent and VGOD, Opportunities Parent may be deemed to beneficially own the shares of Common Stock held directly by VGOD.
  • [F6]The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.

Documents

1 file

Issuer

Inhibrx Biosciences, Inc.

CIK 0002007919

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001103804

Filing Metadata

Form type
4
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 4:41 PM ET
Size
21.6 KB